Press Releases about Merck & Co
Exciting New Cures Possible from GLP-1 Diabetes, Weight-Loss Drugs
January 08, 2024
![]() From Merck & Co., Inc.
Via Business Wire
![]() ![]() ![]() ![]() From Merck & Co., Inc.
Via Business Wire
![]() ![]() ![]()
Merck Provides U.S. Regulatory Update on Gefapixant
December 20, 2023
From Merck & Co., Inc.
Via Business Wire
![]()
Merck to Participate in the Goldman Sachs Healthcare C-Suite Unscripted Conference
December 20, 2023
From Merck & Co., Inc.
Via Business Wire
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]()
Merck Announces First-Quarter 2024 Dividend
November 28, 2023
From Merck & Co., Inc.
Via Business Wire
![]() ![]()
Merck to Acquire Caraway Therapeutics, Inc.
November 21, 2023
From Merck & Co., Inc.
Via Business Wire
![]() From Merck & Co., Inc.
Via Business Wire
![]()
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|